ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 198

$740K Total Retail Price of All Prescriptions

Rank: 25 out of 198

417 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 417 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 417 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,503 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 651 595 1 3
LEVOTHYROXINE SODIUM 545 468 2 1
AMLODIPINE BESYLATE 384 349 3 4
POTASSIUM CHLORIDE 362 311 4 9
BUMETANIDE 299 280 5 105
HYDROCODONE-ACETAMINOPHEN 258 155 S3 6 8
WARFARIN SODIUM 251 221 7 7
CRESTOR 209 183 8 26
SYNTHROID 200 178 9 36
ALLOPURINOL 199 183 10 23
CITALOPRAM HBR 193 172 11 20
FUROSEMIDE 181 162 12 5
ATORVASTATIN CALCIUM 180 161 13 12
METOPROLOL TARTRATE 171 146 14 10
ZOLPIDEM TARTRATE 168 128 15 22
GABAPENTIN 165 143 16 14
LISINOPRIL 156 139 17 6
DIOVAN 137 120 18 34
BYSTOLIC 136 115 19 58
SIMVASTATIN 133 132 20 2
PANTOPRAZOLE SODIUM 126 80 21 31
VENLAFAXINE HCL ER 126 104 21 84
TRAMADOL HCL 122 108 23 15
POLYETHYLENE GLYCOL 3350 118 82 24 41
ROPINIROLE HCL 118 81 24 74
CYCLOBENZAPRINE HCL 116 62 R 26 67
METOPROLOL SUCCINATE 115 104 27 11
NEXIUM 112 60 28 40
CYMBALTA 112 90 28 48
GLIMEPIRIDE 106 80 30 35
CARVEDILOL 105 98 31 24
LANTUS 104 96 32 46
RAMIPRIL 101 85 33 72
TRIAMTERENE-HCTZ 97 73 34 32
PREDNISONE 96 96 35 29
MELOXICAM 90 67 36 30
SPIRONOLACTONE 89 86 37 37
CEPHALEXIN 89 58 37 108
SUCRALFATE 89 71 37 165
METFORMIN HCL 87 68 40 13
PRAVASTATIN SODIUM 87 82 40 19
HYDROCHLOROTHIAZIDE 82 82 42 16
METOCLOPRAMIDE HCL 81 55 43 136
SERTRALINE HCL 80 74 44 25
ATENOLOL 76 75 45 17
ENALAPRIL MALEATE 75 66 46 51
NAMENDA 75 75 46 33
NOVOLOG 74 66 48 107
VESICARE 73 73 49 77
TRICOR 73 59 49 93
LOSARTAN POTASSIUM 73 45 49 18
TAMSULOSIN HCL 68 68 52 27
ZETIA 66 36 53 68
FENTANYL 65 33 S2 54 73
TORSEMIDE 65 53 54 75
SYMBICORT 64 63 56 150
ISOSORBIDE MONONITRATE ER 62 59 57 60
AMITIZA 59 34 58 265
RANITIDINE HCL 58 46 59 54
CIPROFLOXACIN HCL 57 44 60 55
TRIAMTERENE-HYDROCHLOROTHIAZID 56 37 61 142
DIOVAN HCT 55 55 62 88
SINGULAIR 54 43 63 106
PROAIR HFA 54 47 63 80
ESCITALOPRAM OXALATE 51 30 65 53
PREMARIN 51 49 R 65 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.